Navigation Links
Common Heart Drug Might Dampen Some Autism Symptoms
Date:12/11/2012

By Serena Gordon
HealthDay Reporter

TUESDAY, Dec. 11 (HealthDay News) -- A medication typically prescribed to control high blood pressure that's commonly referred to as a water pill may ease some of the symptoms of autism, researchers say.

That's especially true for people who have milder forms of the disorder, the new research indicates.

"Bumetanide is a promising novel therapeutic agent to treat autism," wrote the study's authors, who were quick to point out that this treatment is not a cure for autism and that larger trials need to be done to determine who would benefit most from this treatment.

Results of the study appear online Dec. 11 in the journal Translational Psychiatry.

Autism is a developmental disorder that results in communication problems, social difficulties, repetitive behaviors and restricted interests, according to background information in the study. The exact cause of the disorder isn't yet known, though genetic and environmental factors are believed to play a role.

Scientists have also studied neurotransmitters, suspecting that these chemical messengers in the brain might not be working as they should in people with autism. Gamma-aminobutyric acid (GABA) is one such neurotransmitter, and the medication bumetanide appears to be able to alter the function of GABA, at least in animals, according to the researchers.

In this latest study, the researchers gave 60 children who had been diagnosed with autism or Asperger's syndrome either 1 milligram of bumetanide or an inactive placebo pill daily. All of the children were between 3 and 11, and the study period lasted three months.

The severity of autism was determined by videotaped evaluations done on the first day of the study and the 90th day, by researchers who didn't know which children had received active treatment and which had been given a placebo pill.

Using several standardized autism assessment tools, the researchers found that bumetanide improved autism symptoms. The effects of the medication were more pronounced in children with milder autism. In case reports included in the study, some of the improvements seen included more eye contact, improved non-verbal communication and better social communication.

Side effects were very mild, though the use of the drug does require periodic monitoring for potassium levels; one child in the study had low potassium levels.

Senior study author Yehezkel Ben-Ari, founder of the Institute of Neurobiology of the Mediterranean Sea in Bohars, France, said the authors believe that the improvement in symptoms is due to an effect on GABA caused by the drug.

One expert said the findings look promising.

"This is a very interesting study. The authors have taken a medication that's been on the back shelf for decades and, surprisingly, found a clinically significant benefit when used in children with autism, especially those on the milder end of the spectrum," noted Dr. Andrew Adesman, chief of developmental and behavioral pediatrics at the Steven and Alexandra Cohen Children's Medical Center of New York in New Hyde Park, N.Y.

"Children would need to be on this medication indefinitely, because their improvements deteriorate when the medication is stopped. And, we don't yet know if there are any long-term concerns," he said. "Hopefully, this study will be a catalyst to new research. We need to see additional studies before we can recommend this treatment widely, but since it's already FDA-approved, we should know more in just a few years."

More information

To learn more about autism, visit the U.S. Department of Health and Human Services.

SOURCES: Yehezkel Ben-Ari, Ph.D., founder, Institute of Neurobiology of the Mediterranean Sea, Bohars, France; Andrew Adesman, M.D., chief, developmental and behavioral pediatrics, Steven and Alexandra Cohen Children's Medical Center of New York, New Hyde Park, N.Y.; Dec. 11, 2012, Translational Psychiatry, online


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Kids With Autism Common Users of ERs, Study Says
2. At Least 35 Common Medical Conditions are Contraindicated for Certain Yoga Poses: Prevent Yoga Injury Campaigns to Educate on Yoga Safety
3. Researchers report first success of targeted therapy in most common non-small cell lung cancer
4. Overactive Thyroid May Raise Risk for Common Irregular Heartbeat
5. Kentucky study finds common drug increases deaths in atrial fibrillation patients
6. Mans best friend: Common canine virus may lead to new vaccines for deadly human diseases
7. Costly, Repeat Medical Testing Common for Medicare Patients: Study
8. Obese but happy gene challenges the common perception of link between depression and obesity
9. Study suggests repeat testing common among medicare beneficiaries
10. Genital Injuries Common But Preventable, Researchers Say
11. Study overturns common assumption about knee replacements in morbidly obese individuals
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Common Heart Drug Might Dampen Some Autism Symptoms
(Date:9/21/2017)... FL (PRWEB) , ... September 21, 2017 , ... 38-Year-Old ... Aesthetic Surgery Center in Naples, Florida is pleased to announce that Plastic Surgeon Kiranjeet ... Top 40 Under 40 is an annual award that was started in ...
(Date:9/21/2017)... Chicago, IL (PRWEB) , ... September 21, 2017 , ... ... set to run from September 11 to the end of November. , The Chicago, ... out to their community and teach them about the ease of taking their personal ...
(Date:9/21/2017)... ... September 21, 2017 , ... Promotional ... http://www.fdanews.com/products/54818-promotional-communication      , In the competitive world of drug and device marketing ... in compliance with FDA rules. , The FDA has issued two draft guidances ...
(Date:9/21/2017)... ... September 21, 2017 , ... Demonstrating a consistent and ... departments have been awarded five-year accreditation status through the Public Health Accreditation ... served by a PHAB-accredited health department now extend to more than 203 ...
(Date:9/21/2017)... ... 21, 2017 , ... In addition to sticking with the ... holistic approach and use natural alternatives for all house cleaning products, disinfectants, respiratory ... guaranteeing that, the new line of essential oils, are all 100% organic and ...
Breaking Medicine News(10 mins):
(Date:9/9/2017)... 2017 Dealmed Medical Supplies, New ... equipment, supplies, drugs, vaccines, and specialty medical products and ... agreement to acquire Vantage Medical Supplies, a major distributor ... Holtsville, New York . ... emerging medical practices, will operate under the Dealmed name ...
(Date:9/7/2017)... Sept. 7, 2017  For nearly two decades, New Life Agency has ... Reproduction Insurance industry. Today, New Life Agency announces a powerful three-way partnership ... ... ... http://pharmacarecard.com/ (PRNewsfoto/PharmaCareCard) ...
(Date:9/7/2017)... 7, 2017  Zimmer Biomet Holdings, Inc. (NYSE and ... announced that it will be participating in the Morgan ... the Grand Hyatt hotel in New York.  Zimmer Biomet ... a.m. Eastern Time. A live webcast of ... Relations website at http://investor.zimmerbiomet.com .   ...
Breaking Medicine Technology: